Skip to main content

Table 1 Baseline characteristics of patients included in the study

From: Betaine anhydrous in homocystinuria: results from the RoCH registry

 

CBS deficiency vitamin B6 responder (N = 9)

CBS deficiency vitamin B6 non-responder (N = 49)

MTHFR deficiency (N = 21)

Cbl metabolism defects (N = 45)

Total (N = 125)a

Age, years

 Mean ± SD

34.41 ± 14.4

20.42 ± 12.3

18.14 ± 14.5

8.04 ± 10.3

16.80 ± 14.4

 Median (min, max)

39 (17.6, 56.9)

18 (0.1, 55.5)

20 (0.0, 56.5)

6 (0.0, 44.33)

14 (0.0, 56.9)

Sex, n (%)

 Female

2 (22.2)

18 (36.7)

11 (52.4)

22 (48.9)

54 (43.2)

 Male

7 (77.8)

31 (63.3)

10 (47.6)

23 (51.1)

71 (56.8)

Age at onset of first symptoms, years

 n

9

41

20

44

114

 Mean ± SD

26.01 ± 14.7

5.79 ± 6.3

8.69 ± 12.8

3.02 ± 8.3

6.83 ± 10.9

 Median (min, max)

31 (0.8, 48.0)

4 (0.0, 28.7)

2 (0.0, 50.2)

0 (0.0, 41.2)

2 (0.0, 50.2)

Age at diagnosis, years

 n

9

49

20

45

124

 Mean ± SD

28.10 ± 17.7

7.27 ± 6.2

10.32 ± 14.5

3.45 ± 9.2

8.21 ± 12.2

 Median (min, max)

31 (0.8, 56.6)

6 (0.0, 28.7)

5 (0.0, 56.5)

0 (0.0, 42.2)

4 (0.0, 56.6)

Delay between onset of symptoms and diagnosis, years

 n

9

41

20

44

114

 Mean ± SD

2.10 ± 5.6

2.15 ± 3.2

1.62 ± 2.3

0.50 ± 1.5

1.42 ± 2.9

 Median (min, max)

0 (0.0, 17.0)

1 (0.0,15.0)

0 (0.0, 6.3)

0 (0.0, 7.6)

0 (0.0, 17.0)

Total plasma homocysteine, μmol/L

 n

9

45

18

41

114

 Mean ± SD

118.29 ± 80.63

115 ± 72.86

146.2 ± 78.35

90.54 ± 56.6

111.29 ± 70.31

 Median (min, max)

96 (15.0, 249.9)

98 (12.7, 277)

122.3 (64.5, 389)

71.5 (21.2, 228)

95.45 (12.7, 389)

  1. Cbl cobalamin, CBS cystathionine β-synthase, MTHFR 5, 10-methylenetetrahydrofolate reductase, SD standard deviation
  2. a Includes patient who was CBS-deficient vitamin B6 non responder and MTHFR-deficient